BRIEF-SCYNEXIS says achieves new development milestones for SCY-078

* Pending discussions with FDA, plan to test in upcoming clinical trials of SCY-078
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.